These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16454489)

  • 21. Activity of the Pore-Forming Virulence Factor Listeriolysin O Is Reversibly Inhibited by Naturally Occurring S-Glutathionylation.
    Portman JL; Huang Q; Reniere ML; Iavarone AT; Portnoy DA
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Listeria monocytogenes listeriolysin O and phosphatidylinositol-specific phospholipase C affect adherence to epithelial cells.
    Krawczyk-Balska A; Bielecki J
    Can J Microbiol; 2005 Sep; 51(9):745-51. PubMed ID: 16391652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells.
    Stier EM; Mandal M; Lee KD
    Mol Pharm; 2005; 2(1):74-82. PubMed ID: 15804180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directly Observing the Lipid-Dependent Self-Assembly and Pore-Forming Mechanism of the Cytolytic Toxin Listeriolysin O.
    Mulvihill E; van Pee K; Mari SA; Müller DJ; Yildiz Ö
    Nano Lett; 2015 Oct; 15(10):6965-73. PubMed ID: 26302195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fisetin inhibits Listeria monocytogenes virulence by interfering with the oligomerization of listeriolysin O.
    Wang J; Qiu J; Tan W; Zhang Y; Wang H; Zhou X; Liu S; Feng H; Li W; Niu X; Deng X
    J Infect Dis; 2015 May; 211(9):1376-87. PubMed ID: 25231018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of listeriolysin O oligomerization by lutein prevents Listeria monocytogenes infection.
    Liu B; Teng Z; Wang J; Lu G; Deng X; Li L
    Fitoterapia; 2017 Jan; 116():45-50. PubMed ID: 27884571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Listeriolysin O Affects the Permeability of Caco-2 Monolayer in a Pore-Dependent and Ca2+-Independent Manner.
    Cajnko MM; Marušić M; Kisovec M; Rojko N; Benčina M; Caserman S; Anderluh G
    PLoS One; 2015; 10(6):e0130471. PubMed ID: 26087154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The presentation of class I and class II epitopes of listeriolysin O is regulated by intracellular localization and by intercellular spread of Listeria monocytogenes.
    Hiltbold EM; Safley SA; Ziegler HK
    J Immunol; 1996 Aug; 157(3):1163-75. PubMed ID: 8757622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells.
    Glomski IJ; Gedde MM; Tsang AW; Swanson JA; Portnoy DA
    J Cell Biol; 2002 Mar; 156(6):1029-38. PubMed ID: 11901168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH dependence of listeriolysin O aggregation and pore-forming ability.
    Bavdek A; Kostanjšek R; Antonini V; Lakey JH; Dalla Serra M; Gilbert RJ; Anderluh G
    FEBS J; 2012 Jan; 279(1):126-41. PubMed ID: 22023160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes.
    Mathew E; Hardee GE; Bennett CF; Lee KD
    Gene Ther; 2003 Jul; 10(13):1105-15. PubMed ID: 12808441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous Loss of Virulence in Natural Populations of Listeria monocytogenes.
    Maury MM; Chenal-Francisque V; Bracq-Dieye H; Han L; Leclercq A; Vales G; Moura A; Gouin E; Scortti M; Disson O; Vázquez-Boland JA; Lecuit M
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28827366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleiotropic enhancement of bacterial pathogenesis resulting from the constitutive activation of the Listeria monocytogenes regulatory factor PrfA.
    Mueller KJ; Freitag NE
    Infect Immun; 2005 Apr; 73(4):1917-26. PubMed ID: 15784531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential function of Listeria monocytogenes listeriolysin O and phospholipases C in vacuolar dissolution following cell-to-cell spread.
    Alberti-Segui C; Goeden KR; Higgins DE
    Cell Microbiol; 2007 Jan; 9(1):179-95. PubMed ID: 17222191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of listeriolysin O pH dependence.
    Schuerch DW; Wilson-Kubalek EM; Tweten RK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12537-42. PubMed ID: 16105950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective immunity induced by a LLO-deficient Listeria monocytogenes.
    Yin Y; Zhang C; Dong H; Niu Z; Pan Z; Huang J; Jiao X
    Microbiol Immunol; 2010 Apr; 54(4):175-83. PubMed ID: 20377746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles.
    Birmingham CL; Canadien V; Kaniuk NA; Steinberg BE; Higgins DE; Brumell JH
    Nature; 2008 Jan; 451(7176):350-4. PubMed ID: 18202661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.
    Kim NH; Provoda C; Lee KD
    Mol Pharm; 2015 Feb; 12(2):342-50. PubMed ID: 25521817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid purification of recombinant listeriolysin O (LLO) from Escherichia coli.
    Churchill RL; Lee H; Hall JC
    J Ind Microbiol Biotechnol; 2005 Aug; 32(8):355-63. PubMed ID: 16052337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human lymphocytic B-leukemia cell line treatment with the bacterial toxin listeriolysin O and rituximab (anti-CD20 antibody): Effects of similar localization of their receptors.
    Gryzik M; Grzywocz Z; Wasilewska D; Kawiak J; Stachowiak R; Bielecki J; Hoser G
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):329-40. PubMed ID: 26216910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.